Fundraising FoxElysia Capital — 2014 Investments
1 investments dated 2014 · listed companies and verified rows first · show all
Abeona Therapeuticsabeonatherapeutics.comin𝕏NASDAQ: ABEOOct 2014
Abeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases with high unmet need, including its approved product ZEVASKYN and its lead PSMA-targeted T cell therapy ABO-701 for advanced prostate cancer.
BiotechDigital HealthHealthtechMedical DevicesCleveland, US
Timothy Miller(President, Chief Executive Officer and Manager)in
BoardAl Hawkins(Chairman and Manager)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.